Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 StudyTaofeek K. Owonikoko, Suresh S. Ramalingam, Bradley W. Lash et al.|Journal of Clinical Oncology|2018Cited by 193
Randomized trial of cisplatin and etoposide in combination with veliparib or placebo for extensive stage small cell lung cancer: ECOG-ACRIN 2511 study.Taofeek K. Owonikoko, Suresh S. Ramalingam, Suzanne E. Dahlberg et al.|Journal of Clinical Oncology|2017Cited by 10
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6.David Andorsky, Jeff P. Sharman, Mariana Sacchi et al.|Journal of Clinical Oncology|2024Cited by 2